ECR: What makes small ovarian lesions light up like a lightbulb?

Research presented at ECR 2024 suggests that diffusion-weighted MRI (DW-MRI) has value in ovarian cancer treatment planning. In his talk, Max Lahaye, MD, PhD, from the Netherlands Cancer Institute in Amsterdam discussed his team's findings which showed that DW-MRI could perform a complete primary and interval debulking with high accuracy.Max Lahaye, MD, of the Netherlands Cancer Institute in Amsterdam presents findings on the clinical impact of dedicated MR staging of ovarian cancer patients during ECR 2024. The Netherlands Cancer Institute, Leiden University Medical Center, and Catharina Ziekenhuis Teaching Hospital are collaborating on the multicenter MISSION trial. Part of the trial's overarching work includes predicting whether complete debulking surgery could be achieved and whether or not DW-MRI could be a cost-effective method in the diagnostic work-up of advanced ovarian cancer. The researchers designed their prospective study to follow a routine care path. The study also evaluated surgical outcomes, interobserver agreement, and whether MRI could depict small lesions not detected during the initial surgical inspection. The study included 220 advanced-stage (FIGO III/IV) ovarian cancer patients ages 65 to 67 who were scheduled for primary (n = 27) or interval (n = 193) debulking between 2018 and 2023. Anyone with contraindications for debulking or MRI, and no prior malignancy up to five years before surgery, was excluded. Although surgeons use a scoring system ca...
Source: AuntMinnie.com Headlines - Category: Radiology Authors: Tags: MRI Womens Imaging Ob/Gyn Source Type: news